Monsanto Company's Global Performance Drives 25 Percent 2012 Ongoing Earnings Per Share Growth; Company Underscores Mid-Teens Ongoing Earnings Per Share Growth Opportunity In 2013

Company Projects 2013 Ongoing and As-Reported Earnings Per Share Guidance of $4.18 to $4.32

Oct 03, 2012, 08:00 ET from Monsanto Company

ST. LOUIS, Oct. 3, 2012 /PRNewswire/ -- Monsanto Company (NYSE: MON) today announced it concluded fiscal year 2012 with ongoing earnings per share growth of 25 percent, and added that it is well-positioned to attain mid-teens ongoing earnings per share growth next year. The company delivered growth in its base business in the United States on the continued adoption of its key corn and soybean platforms, complemented by international seeds and traits performance. Executives also highlighted early 2012 U.S. corn harvest results, which reinforce Monsanto's long-standing yield advantage even in one of the most difficult growing seasons on record.

Fourth Quarter

Fiscal Year

($ in millions)

2012

2011

2012

2011

Net Sales By Segment

Corn seed and traits

$

588

$

671

$

5,814

$

4,805

Soybean seed and traits

142

96

1,771

1,542

Cotton seed and traits

29

181

779

847

Vegetable seeds

284

267

851

895

All other crops seeds and traits

172

136

586

493

TOTAL Seeds and Genomics

$

1,215

$

1,351

$

9,801

$

8,582

Agricultural productivity

$

895

$

896

$

3,715

$

3,240

TOTAL Agricultural Productivity

$

895

$

896

$

3,715

$

3,240

TOTAL Net Sales

$

2,110

$

2,247

$

13,516

$

11,822

Gross Profit

$

881

$

972

$

7,045

$

6,079

Operating Expenses

$

1,137

$

1,042

$

3,897

$

3,577

Interest Expense – Net

$

34

$

22

$

114

$

88

Other Expense (Income) – Net

$

$

2

$

46

$

40

Net Income (Loss) Attributable to Monsanto Company

$

(229)

$

(112)

$

2,045

$

1,607

Diluted Earnings (Loss) per Share (See note 1.)

$

(0.42)

$

(0.21)

$

3.79

$

2.96

Items Affecting Comparability – EPS Impact

Restructuring charges, net

$

(0.02)

$

(0.01)

$

(0.02)

$

Income on discontinued operations

(0.01)

Nitro claims settlement

0.05

Resolution of a legacy tax matter

(0.11)

Diluted Earnings (Loss)  per Share from Ongoing Business (For the definition of ongoing EPS, see note 1.)

$

(0.44)

$

(0.22)

$

3.70

$

2.96

Effective Tax Rate

24%

3%

30%

30%

 

 

Fourth Quarter

Fiscal Year

Comparison as a Percent of Net Sales:

2012

2011

2012

2011

Gross profit

42

%

43

%

52

%

51

%

Selling, general and administrative expenses (SG&A)

34

%

29

%

18

%

19

%

Research and development expenses

21

%

18

%

11

%

12

%

Income (Loss) from continuing operations before income taxes

(14)

%

(4)

%

22

%

20

%

Net income (Loss) attributable to Monsanto Company

(11)

%

(5)

%

15

%

14

%

"We've proven our business on a global stage with back-to-back years of tremendous performance and momentum," said Hugh Grant, chairman and chief executive officer for Monsanto. "With more waves of innovation and global opportunities than ever before, I'm confident that by building off what we accomplished in 2012 we can achieve steady growth in fiscal year 2013 as we continue to deliver sustainable yield to our farmer customers."

Results of Operations

Monsanto reported net sales of $2.1 billion for the fourth quarter of fiscal year 2012.  Net sales for the full fiscal year were $13.5 billion, a 14 percent increase over fiscal year 2011. Full year net sales results were driven primarily by higher global corn seeds and traits revenue, and increased soybean seeds and traits revenue in the United States and Brazil.

Seeds and Genomics segment net sales were $1.2 billion for the quarter, a decrease from the prior year.  For the fiscal year, net sales for the Seeds and Genomics segment reached $9.8 billion, a 14 percent increase over the prior year. Agricultural Productivity segment net sales were $895 million for the quarter.  Net sales for the Agricultural Productivity segment for the fiscal year grew to $3.7 billion

Monsanto reported a net loss of $229 million in the fourth quarter of fiscal year 2012, compared with a reported net loss of $112 million in the same period last year.  Net income for fiscal year 2012 was $2 billion, an increase over fiscal year 2011 net income of $1.6 billion.

The company's fiscal year 2012 earnings per share (EPS) was $3.70 on an ongoing basis and $3.79 on an as-reported basis.  For the fourth quarter, the company reported a loss per share of $0.44 on an ongoing basis and $0.42 on an as-reported basis.  (For a reconciliation of ongoing EPS, see page 1 and note 1.)

Cash Flow

For fiscal year 2012, net cash provided by operating activities was a source of $3 billion, compared with a source of $2.8 billion in fiscal year 2011. Net cash required by investing activities was $1 billion in fiscal year 2012, compared with net cash required of $975 million last year. Net cash required by financing activities was $1.2 billion for fiscal year 2012, compared with net cash required of $864 million in fiscal year 2011. Free cash flow was a source of $2 billion for fiscal year 2012, compared to a source of $1.8 billion in fiscal year 2011. (For a reconciliation of free cash flow, see note 1.) 

Outlook

In fiscal year 2013, Monsanto expects to achieve mid-teens ongoing EPS growth off the 2012 base of $3.70 for a range of $4.18 to $4.32. The company expects as-reported EPS to also be in the range of $4.18 to $4.32.  (For a reconciliation of 2013 EPS guidance, see note 1.)

The Seeds and Genomics segment is expected to deliver gross profit in the range of $6.55 billion in 2013, with gross profit growth projected to be divided roughly evenly between the United States and international regions.

Gross profit for the Agricultural Productivity segment next year is expected in the range of $1 billion.

The company projects free cash flow in the range of $1.7 billion to $1.8 billion for fiscal year 2013.  The company expects net cash provided by operating activities to be $2.8 billion to $3.1 billion, and net cash required by investing activities to be approximately $1.1 billion to $1.3 billion for fiscal year 2013. (For a reconciliation of free cash flow, see note 1.) 

In fiscal year 2013, the company expects selling, general and administrative expenses to be in the range of $2.55 billion. The company's research and development spend is projected in the range of $1.53 billion for fiscal year 2013.

Seeds and Genomics Segment Detail

($ in millions)

Net Sales

Gross Profit

Seeds and Genomics

Fourth Quarter

Fiscal Year

Fourth Quarter

Fiscal Year

2012

2011

2012

2011

2012

2011

2012

2011

Corn Seed and Traits

$

588

$

671

$

5,814

$

4,805

$

284

$

340

$

3,589

$

2,864

Soybean Seed and Traits

142

96

1,771

1,542

81

92

1,160

1,045

Cotton Seed and Traits

29

181

779

847

18

140

585

642

Vegetable Seeds

284

267

851

895

159

173

419

534

All Other Crops Seeds and Traits

172

136

586

493

89

45

306

221

TOTAL Seeds and Genomics

$

1,215

$

1,351

$

9,801

$

8,582

$

631

$

790

$

6,059

$

5,306

 

($ in millions)

Earnings (Loss) Before Interest & Taxes (EBIT)

Fourth Quarter

Fiscal Year

Seeds and Genomics

2012

2011

2012

2011

EBIT (For a reconciliation of EBIT, see note 1.)

$

(387)

$

(157)

$

2,570

$

2,106

Unusual Items Affecting EBIT: Restructuring

$

10

$

4

$

10

$

(11)

 

The Seeds and Genomics segment consists of the company's global seeds and related traits business.

For the fiscal year, Monsanto realized Seeds and Genomics segment sales of $9.8 billion, reflecting a 14 percent increase over the prior year. Segment sales in the fourth quarter were $1.2 billion, a decrease from the prior year period.

In the United States, branded seed volume in fiscal year 2012 grew by the largest increment in three years and outpaced market expansion. In corn, the company reached 27 million planted U.S. acres for its Genuity® Reduced Refuge Family. While harvest is still in progress, the company shared some early highlights of what the 2012 U.S. corn harvest has shown to date:

  • In a year when average corn yields are significantly down, DEKALB® continues its historic advantage relative to competitive products. In 2012, DEKALB® is outperforming competitive products with approximately a 8 bushels per acre national yield advantage, with Monsanto's germplasm providing greater consistency in performance amidst this season's drought conditions. Results to date by region also show an advantage over competitors for DEKALB®, including approximately a 9 bushels per acre yield advantage in the Central Corn Belt and approximately a 8 bushels per acre yield advantage in the Southern Region.
  • Monsanto's Genuity® DroughtGard Hybrids system, which combines germplasm selected for its drought-tolerant characteristics, the drought-tolerant biotechnology trait and agronomic recommendations, has demonstrated strong performance in Ground Breakers℠ on-farm testing this season. Compared head-to-head to competitor hybrids marketed to the drought segment, DroughtGard Hybrids results across the Western Great Plains show approximately a 5 bushels per acre yield advantage to date. 

In 2013, the company is targeting 36 million to 38 million acres for the Reduced Refuge Family. Genuity® VT Triple PRO® RIB Complete®, a convenient, single-bag refuge option, will join Genuity® SmartStax® RIB Complete® and Genuity® VT Double PRO® RIB Complete® corn blends as an additional product choice available for the 2013 season. The DroughtGard Hybrids system will also be introduced in 2013 in the Western Great Plains under stewardship requirements pending import approvals in key export markets.

In soybeans, the company reached a total of 32 million acres for its Genuity® Roundup Ready 2 Yield® product in the United States. The company expects the Genuity® Roundup Ready 2 Yield® platform growth to continue, targeting 39 million to 41 million acres in 2013.

In 2013, the company expects Latin America to again be a strong source of growth complementing the U.S. business, driven by the continued corn opportunity in Brazil and Argentina. In Argentina, the company has introduced Genuity® VT Triple PRO® corn as another product choice for farmers and expects the acceleration of the conversion of double stacks to the triple-stack product. Similarly, in Brazil, growers choosing to upgrade from single trait corn products to the first double stack, VT PRO 2, is also expected to accelerate. Complementing the continued strong adoption of the company's next-generation soy platform in the United States, the Intacta RR2 PRO soybean product is expected to be a driver of growth with expanded Ground Breakers℠ on-farm testing planned for 2013 as the product ramps up for commercial launch in Brazil and is introduced in other countries in coming years.

Vegetable sales, up in the fourth quarter compared to the prior year period, were down year-over-year. In 2013, the company expects the vegetable business to return to growth and continues to anticipate it elevating to its third largest crop platform in terms of gross profit in the coming years. Cotton revenue decreased year-over-year due in part to acre shifts to other crops.

Agricultural Productivity Segment Detail

($ in millions)

Net Sales

Gross Profit

Fourth Quarter

Fiscal Year

Fourth Quarter

Fiscal Year

2012

2011

2012

2011

2012

2011

2012

2011

Agricultural Productivity

$

895

$

896

$

3,715

$

3,240

$

250

$

182

$

986

$

773

TOTAL Agricultural Productivity

$

895

$

896

$

3,715

$

3,240

$

250

$

182

$

986

$

773

 

($ in millions)

Earnings (Loss) Before Interest & Taxes (EBIT)

Agricultural Productivity

Fourth Quarter

Fiscal Year

2012

2011

2012

2011

EBIT (For a reconciliation of EBIT, see note 1.)

$

123

$

59

$

477

$

281

Unusual Items Affecting EBIT:

Restructuring

$

$

4

$

$

8

EBIT from Discontinued Operations

$

2

$

(1)

$

10

$

3

Nitro Claims Settlement

$

$

$

(44)

$

The Agricultural Productivity segment consists of the crop protection products and lawn-and-garden herbicide products.

Segment sales for the quarter reached $895 million with gross profit of $250 million.  For the fiscal year, the segment delivered net sales of $3.7 billion with gross profit of $986 million, with year-over-year increases that reflect strong performance from the company's Roundup®, lawn-and-garden and selective herbicides businesses.

Webcast Information     

In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central time (9:30 a.m. eastern time) today. The call will focus on these results and future expectations and may include a discussion of Monsanto's strategic initiatives, product performance and other matters related to the company's business.

Presentation slides and a simultaneous audio webcast of the conference call may be accessed by visiting the company's web site at www.monsanto.com/investors or by visiting http://edge.media-server.com/m/p/763un9g6/lan/en. Visitors may need to download Windows Media Player™ prior to listening to the webcast. Following the live broadcast, a replay of the webcast will be available on the Monsanto Web site for three weeks.

About Monsanto Company Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com.  Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at www.monsantoblog.com, or subscribe to our News Release RSS Feed.

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits and the previously-announced SEC investigation; the previously reported material weakness in our internal controls over financial reporting; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent Form 10-K Report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

Notes to editors: Monsanto and the Vine Design, DEKALB, Genuity, SmartStax, RIB Complete, VT Triple PRO, VT PRO 2, VT Double PRO, DroughtGard, Intacta RR2 PRO and Roundup Ready 2 Yield are trademarks of Monsanto Company and its wholly-owned subsidiaries.

Contact

Media: Sara Miller (314-694-5824)

Analysts: Bryan Hurley (314-694-8148)

 

Monsanto Company

Selected Financial Information

(Dollars in millions, except per share amounts)

Unaudited

 

Statements of Consolidated Operations

Three Months Ended

Twelve Months Ended

Aug. 31,

Aug. 31,

2012

2011

2012

2011

Net Sales

$

2,110

$

2,247

$

13,516

$

11,822

Cost of Goods Sold

1,229

1,275

6,471

5,743

Gross Profit

881

972

7,045

6,079

Operating Expenses:

Selling, general and administrative expenses

709

647

2,390

2,190

Research and development expenses

438

403

1,517

1,386

Restructuring charges, net

(10)

(8)

(10)

1

Total Operating Expenses

1,137

1,042

3,897

3,577

Income (Loss) From Operations

(256)

(70)

3,148

2,502

Interest Expense

52

45

191

162

Interest Income

(18)

(23)

(77)

(74)

Other Expense (Income), Net

2

46

40

Income (Loss) from Continuing Operations Before Income Taxes

(290)

(94)

2,988

2,374

Income Tax Provision (Benefit)

(70)

3

901

717

Income (Loss) from Continuing Operations Including Portion

Attributable to Noncontrolling Interest

$

(220)

$

(97)

$

2,087

$

1,657

Discontinued Operations:

Income (Loss) from Operations of Discontinued Businesses

2

(1)

10

3

Income Tax Provision

1

4

1

Income (Loss) on Discontinued Operations

1

(1)

6

2

Net Income (Loss)

$

(219)

$

(98)

$

2,093

$

1,659

Less: Net Income Attributable to Noncontrolling Interest

10

14

48

52

Net Income (Loss) Attributable to Monsanto Company

$

(229)

$

(112)

$

2,045

$

1,607

EBIT (see note 1)

$

(264)

$

(98)

$

3,047

$

2,387

Basic Earnings (Loss) per Share Attributable to Monsanto Company:

Income (Loss) from Continuing Operations

$

(0.43)

$

(0.21)

$

3.82

$

2.99

Income on Discontinued Operations

(0.01)

0.01

0.01

Net Income (Loss) Attributable to Monsanto Company

$

(0.44)

$

(0.21)

$

3.83

$

3.00

Diluted Earnings (Loss) per Share Attributable to Monsanto Company:

Income (Loss) from Continuing Operations

$

(0.42)

$

(0.21)

$

3.78

$

2.96

Income (Loss) on Discontinued Operations

0.01

Net Income (Loss) Attributable to Monsanto Company

$

(0.42)

$

(0.21)

$

3.79

$

2.96

Weighted Average Shares Outstanding:

Basic

533.5

535.1

534.1

536.5

Diluted

539.1

540.8

540.2

542.4

 

Monsanto Company

Selected Financial Information

(Dollars in millions)

Unaudited

 

Condensed Statements of Consolidated Financial Position

As of

As of

Aug. 31, 2012

Aug. 31, 2011

Assets

Current Assets:

Cash and cash equivalents (variable interest entities restricted - 2012: $120 and 2011: $96)

$

3,283

$

2,572

Short-term investments

302

302

Trade receivables, net (variable interest entities restricted - 2012: $52 and 2011: $51)

1,897

2,117

Miscellaneous receivables

622

629

Deferred tax assets

597

446

Inventory, net

2,836

2,591

Other current assets

183

152

Total Current Assets

9,720

8,809

Property, Plant and Equipment, Net

4,365

4,394

Goodwill

3,436

3,365

Other Intangible Assets, Net

1,237

1,309

Noncurrent Deferred Tax Assets

488

873

Long-Term Receivables, Net

376

475

Other Assets

602

619

Total Assets

$

20,224

$

19,844

Liabilities and Shareowners' Equity

Current Liabilities:

Short-term debt, including current portion of long-term debt

36

678

Accounts payable

794

839

Income taxes payable

75

117

Accrued compensation and benefits

546

427

Accrued marketing programs

1,281

1,110

Deferred revenues

396

373

Grower production accruals

194

87

Dividends payable

200

161

Customer payable

14

94

Restructuring reserves

24

Miscellaneous short-term accruals

685

819

Total Current Liabilities

4,221

4,729

Long-Term Debt

2,038

1,543

Postretirement Liabilities

543

509

Long-Term Deferred Revenue

245

337

Noncurrent Deferred Tax Liabilities

313

152

Long-Term Portion of Environmental and Litigation Reserves

213

176

Other Liabilities

615

682

Monsanto Shareowners' Equity

11,833

11,545

Noncontrolling Interest

203

171

Total Shareowners' Equity

12,036

11,716

Total Liabilities and Shareowners' Equity

$

20,224

$

19,844

Debt to Capital Ratio:

15%

16%

 

Monsanto Company

Selected Financial Information

(Dollars in millions)

Unaudited

 

Statements of Consolidated Cash Flows

Twelve Months Ended Aug. 31,

2012

2011

Operating Activities:

Net Income

$

2,093

$

1,659

Adjustments to reconcile cash provided (required) by operating activities:

Items that did not require (provide) cash:

Depreciation and amortization

622

613

Bad-debt expense

3

3

Stock-based compensation expense

128

104

Excess tax benefits from stock-based compensation

(50)

(36)

Deferred income taxes

292

135

Restructuring charges, net

(10)

1

Equity affiliate income, net

(19)

(21)

Net gain on sales of a business or other assets

(4)

(5)

Other items

105

81

Changes in assets and liabilities that provided (required) cash, net of acquisitions:

Trade receivables, net

89

(310)

Inventory, net

(419)

156

Deferred revenues

(43)

62

Accounts payable and other accrued liabilities

379

894

Restructuring cash payments

(12)

(183)

Pension contributions

(83)

(291)

Other items

(20)

(48)

Net Cash Provided by Operating Activities

3,051

2,814

Cash Flows Provided (Required) by Investing Activities:

Purchases of short-term investments

(746)

(732)

Maturities of short-term investments

746

430

Capital expenditures

(646)

(540)

Acquisitions of businesses, net of cash acquired

(322)

(99)

Technology and other investments

(77)

(55)

Other investments and property disposal proceeds

11

21

Net Cash Required by Investing Activities

(1,034)

(975)

Cash Flows Provided (Required) by Financing Activities:

Net change in financing with less than 90-day maturities

(116)

69

Short-term debt proceeds

30

84

Short-term debt reductions

(42)

(74)

Long-term debt proceeds

499

299

Long-term debt reductions

(629)

(193)

Payments on other financing

(1)

Debt issuance costs

(5)

(5)

Treasury stock purchases

(432)

(502)

Stock option exercises

117

65

Excess tax benefits from stock-based compensation

50

36

Tax withholding on restricted stock and restricted stock units

(19)

(4)

Dividend payments

(642)

(602)

Proceeds from noncontrolling interests

101

69

Dividend payments to noncontrolling interests

(77)

(105)

Net Cash Required by Financing Activities

(1,165)

(864)

Cash Assumed from Initial Consolidations of Variable Interest Entities

77

Effect of Exchange Rate Changes on Cash and Cash Equivalents

(141)

35

Net Increase in Cash and Cash Equivalents

711

1,087

Cash and Cash Equivalents at Beginning of Period

2,572

1,485

Cash and Cash Equivalents at End of Period

$

3,283

$

2,572

 

Monsanto Company

Selected Financial Information

(Dollars in millions, except per share amounts)

Unaudited

1.

EBIT, Ongoing EPS and Free Cash Flow: The presentations of EBIT, ongoing EPS and free cash flow are not intended to replace net income (loss) attributable to Monsanto Company, cash flows, financial position or comprehensive income (loss), and they are not measures of financial performance as determined in accordance with generally accepted accounting principles (GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS and free cash flow to the respective most directly comparable financial measure calculated in accordance with GAAP.

Reconciliation of EBIT to Net Income (Loss): EBIT is defined as earnings (loss) before interest and taxes. Earnings (loss) is intended to mean net income (loss) attributable to Monsanto Company as presented in the Statements of Consolidated Operations under GAAP. The following table reconciles EBIT to the most directly comparable financial measure, which is net income (loss) attributable to Monsanto.

 

Three Months Ended

Twelve Months Ended

Aug. 31,

Aug. 31,

2012 

2011

2012

2011

EBIT – Seeds and Genomics Segment

$

(387)

$

(157)

$

2,570

$

2,106

EBIT – Agricultural Productivity Segment

 123 

59

477

281

EBIT– Total

 (264)

(98)

3,047

2,387

Interest Expense, Net

 34 

22

114

88

Income Tax Provision (Benefit)(A)

 (69)

(8)

888

692

Net Income (Loss) Attributable to Monsanto Company

$

(229)

$

(112)

$

2,045

$

1,607

 

(A)

Includes the income tax provision from continuing operations, the income tax provision (benefit) on noncontrolling interest, and the income tax provision on discontinued operations.

Reconciliation of EPS to Ongoing EPS:  Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations.

 

Fiscal Year

Three Months Ended

Twelve Months Ended

2013

Aug. 31,

Aug. 31,

Guidance

2012

2011

2012

2011

Diluted Earnings (Loss) per Share

$4.18-$4.32

$

(0.42)

$

(0.21)

$

3.79

$

2.96

Restructuring Charges, Net

(0.02)

(0.01)

(0.02)

Income on Discontinued Operations

(0.01)

Nitro Claims Settlement

0.05

Resolution of a Legacy Tax Matter

(0.11)

Diluted Earnings (Loss) per Share from Ongoing Business

$4.18-$4.32

$

(0.44)

$

(0.22)

$

3.70

$

2.96

 

Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating activities and investing activities, as reflected in the Statements of Consolidated Cash Flows presented in this release. With respect to the fiscal year 2013 free cash flow guidance, Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing Activities because in order to prepare any such estimate or projection, Monsanto would need to rely on market factors and conditions that are outside of its control.

Fiscal Year

Twelve Months Ended

2013

Aug. 31,

Guidance

2012

2011

Net Cash Provided by Operating Activities

$

2,800-3,100

$

3,051

$

2,814

Net Cash Required by Investing Activities

(1,100)-(1,300)

(1,034)

(975)

Free Cash Flow

$

1,700-1,800

$

2,017

$

1,839

Net Cash Required by Financing Activities

N/A

(1,165)

(864)

Cash Assumed from Initial Consolidations of Variable Interest Entities

N/A

77

Effect of Exchange Rate Changes on Cash and Cash Equivalents

N/A

(141)

35

Net Increase in Cash and Cash Equivalents

N/A

711

1,087

Cash and Cash Equivalents at Beginning of Period

N/A

2,572

1,485

Cash and Cash Equivalents at End of Period

N/A

$

3,283

$

2,572

SOURCE Monsanto Company



RELATED LINKS

http://www.monsanto.com